NCT07508449

Brief Summary

The study project aims to implement therapeutic patient education for migraine, promoting improvement in outpatient clinical practice by providing counseling moments specifically dedicated to known health risk factors (sedentary lifestyle, physical inactivity, unhealthy eating habits), thanks to the integration of the skills of Neurology Specialists and those of CURIAMo.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
140

participants targeted

Target at P50-P75 for not_applicable

Timeline
8mo left

Started Feb 2025

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress65%
Feb 2025Feb 2027

Study Start

First participant enrolled

February 3, 2025

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

February 12, 2026

Completed
2 months until next milestone

First Posted

Study publicly available on registry

April 2, 2026

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 3, 2026

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 3, 2027

Expected
Last Updated

April 2, 2026

Status Verified

March 1, 2026

Enrollment Period

1.2 years

First QC Date

February 12, 2026

Last Update Submit

March 31, 2026

Conditions

Keywords

migraineexerciseinterdisciplinary approach

Outcome Measures

Primary Outcomes (1)

  • Number of migraine attacks/month and Physical Activity levels

    Relationships between lifestyle (in particular Physical Activity levels, and the number of migraine attacks/month

    From the time of enrollment and at 6/12 months

Secondary Outcomes (50)

  • Age

    At the time of enrollment

  • Blood glucose value

    at the time of enrollment and at 6/12 months

  • Weight

    at the time of enrollement and after 6 and 12 months

  • Days lost or limited in activities over 3 months for migraine

    at the time of enrollment and at 6/12 months

  • Impact of migraine on daily life

    At the time of enrolment and at 6 and 12 months.

  • +45 more secondary outcomes

Study Arms (2)

Group 1, 70 people with migraine in standard treatment (control arm).

ACTIVE COMPARATOR

Standard care

Other: Standard neurological visit at the Headache Centre

Group 2, n° 70 people with migraine in standard treatment + adapted exercise program supervised

EXPERIMENTAL

Standard care plus supervised exercise program

Behavioral: exercise program supervised by specialized kinesiologistsOther: Standard neurological visit at the Headache Centre

Interventions

The duration of the program is 12 weeks, with 2 sessions per week of mixed activities (aerobic exercises + muscle strengthening exercises). Each session lasts about 60 minutes, including a warm-up phase, a central phase and a cool-down phase. In particular, for aerobic exercises, the central phase involves the use of various ergometers (e.g. treadmill and cycle ergometer) and a moderate intensity of training (55-69% of Heart Rate Reserve), while for muscle strengthening exercises will be administered bodyweight exercises, with small tools (e.g. elastic bands, medicine ball, etc.) or with isotonic machines (e.g. lat machines and leg presses), with an initial work intensity of 45-50% of One Repetition Maximum.

Group 2, n° 70 people with migraine in standard treatment + adapted exercise program supervised

Participants will be invited to participate a: 1. \- specialist visit at the Headache Centre; 2. a - anthropometric, metabolic, and dietary assessment; 2b - self-administered (via a digital, online, form divided into four parts) and researcher-administered questionnaires; 2c - kinesiological assessment of functional capacities (aerobic capacity, muscle strength and flexibility); 2d - complete postural evaluation (divided into objective, instrumental, functional and neuromotor examination); 2e - traditional/complete gnathological evaluation, according to international diagnostic criteria.

Group 1, 70 people with migraine in standard treatment (control arm).Group 2, n° 70 people with migraine in standard treatment + adapted exercise program supervised

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Migraine with and without aura.
  • Number of attacks month ≥ 8 and \< 15 for episodic high-frequency patients and ≥ 15 for chronic migraine patients for at least 3 months.
  • Age 18 to 65 years at screening.
  • Physical inactivity (defined as insufficient amount of physical activity practiced according to current guidelines, i.e. \<150 min./week).
  • Ability to walk independently at the time of assessment.

You may not qualify if:

  • Age \< 18 years or older than 65 years;
  • clinical evidence of significant cardiovascular, central nervous system, and musculoskeletal disease that may limit or contraindicate exercise practice.
  • Failure to give consent to the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

CURIAMo

Perugia, PG, 06126, Italy

Location

Centro Cefalee c/o Ospedale Santa Maria della Misericordia, Azienda Ospedaliera di Perugia

Perugia, PG, 06132, Italy

Location

MeSH Terms

Conditions

Migraine DisordersMotor Activity

Condition Hierarchy (Ancestors)

Headache Disorders, PrimaryHeadache DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesBehavior

Study Officials

  • Paola Sarchielli

    Centro Cefalee dell'Azienda Ospedaliera di Perugia

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Two arms, randomized, controlled study
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 12, 2026

First Posted

April 2, 2026

Study Start

February 3, 2025

Primary Completion

May 3, 2026

Study Completion (Estimated)

February 3, 2027

Last Updated

April 2, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations